In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: A nationwide Danish cohort study

BMJ Open

Volumn 3, Issue 9, 2013, Pages

  Laugesen, Kristina ^a   Olsen, Morten Smærup ^a   Andersen, Ane Birgitte Telén ^a   Frøslev, Trine ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DIAGNOSTIC TEST; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOTHER; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PUERPERAL DEPRESSION; RISK FACTOR;

EID: 84885333182     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003507     Document Type: Article

References (30)

1. Bennett HA, Einarson A, Taddio A., et al Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698-709. (Pubitemid 40459031)
2. http://www.sst.dk/Nyhedscenter/Nyheder/2007/nye-tal-20-07.aspx (accessed 29 Mar 2013).
3. Bennett HA, Einarson A, Taddio A., et al Depression during pregnancy: overview of clinical factors. Clin Drug Invest 2004;24:157-79. (Pubitemid 38445264)
4. Pajulo M, Savonlahti E, Sourander A., et al Antenatal depression, substance dependency and social support. J Affect Disord 2001;65:9-17. (Pubitemid 32411567)
5. Zuckerman B, Amaro H, Baucher H., et al Depressive symptoms during pregnancy: relationship to poor health behaviours. Am J Obstet Gynecol 1989;160:1107-11. (Pubitemid 19144468)
6. Grote NK, Bridge JA, Gavin A.R., et al A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010;67:1012-24.
7. Chambers CD, Johnson KA, Dick L.M., et al Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-15. (Pubitemid 26338730)
8. Wen SW, Yang Q, Garner P., et al Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006;194:961-6.
9. Pedersen LH, Henriksen TB, Vestergaard M, et al Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009;339:b3569.
10. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87. (Pubitemid 43209105)
11. Coleman FH, Christensen HD, Gonzalez C.L., et al Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil). Am J Obstet Gynecol 1999;181:1166-71.
12. Maciag D, Simpson KL, Coppinger D, et al Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006;31:47-57. (Pubitemid 43250940)
13. Homberg JR, Schubert D, Caspar P. New perspectives on the neurodevelopmental effects of the SSRIs. Trends Pharmacol Sci 2010;31:60-5.
14. WYD P. 2000. http://www.adhd.org.nz/ICD101.html (accessed 15 Feb 2013).
15. Polanczyk G, de Lima MS, Horta BL, et al The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8. (Pubitemid 46972911)
16. Chu SM, Tsai MH, Hwang F.M., et al The relationship between attention deficit hyperactivity disorder and premature infants in Taiwanese: a case control study. BMC Psychiatry 2012;12:85.
17. Polanska K, Jurewicz J, Hanke W. Exposure to environmental and lifestyle factors and attention-deficit/hyperactivity disorder in children-a review of epidemiological studies. Int J Occup Med Environ Health 2012;25:330-55.
18. Faraone SV, Perlis RH, Doyle A.E., et al Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1313-23. (Pubitemid 40798551)
19. Swanson JM, Kinsbourne M, Nigg J., et al Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 2007;17:39-59. (Pubitemid 46355008)
20. Linnet KM, Dalsgaard S, Obel C., et al Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003;160:1028-40. (Pubitemid 41070961)
21. Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in offspring. J Dev Behav Pediatr 2010;31:641-8.
22. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998;45:320-3. (Pubitemid 28313542)
23. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011;39:22-5.
24. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39:38-41.
25. http://medical-dictionary.thefreedictionary.com/trimester (accessed 31 Mar 2013).
26. Mors O, Perto GP, Mortensen PB The Danish Psychiatric Central Research Register. Scand J Public Health 2011;39:54-7.
27. Andersen TF, Madsen M, Jorgensen J., et al The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8. (Pubitemid 29299976)
28. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972;34:187-220.
29. Frisell T, Öberg S, Kuja-Halkola R, et al. Sibling comparison designs: bias from non-shared confounders and measurement error. Epidemiology 2012;23:713-20.
30. McIntosh D, Kutcher S, Binder C., et al Adult ADHD and comorbid depression: a consensus-derived algorithm for ADHD. Neuropsychiatry Dis Treat 2009;5:137-50.